盐酸替罗非班对急性心肌梗死冠脉多支病变经皮冠状动脉介入术后疗效及安全性研究

doi:10.3969/j.issn.1006-6233.2017.10.026

摘要
图/表
参考文献
相关文章 (12)

全文: PDF (1389 KB) HTML (1 KB)
输出: BibTeX | EndNote (RIS)

摘要 目的: 探讨盐酸替罗非班的应用对接受急性心肌梗死冠脉多支病变经皮冠状动脉介入术(PCI)患者的术后疗效及安全性研究。方法: 选取前来我院进行急诊治疗的126例急性心肌梗死冠脉多支病变患者作研究对象,简单随机化分组,按随机原则将其分为对照组和治疗组,每组各63例。对照组患者进行经皮冠状动脉介入术急诊治疗;治疗组在对照组治疗基础上联合使用盐酸替罗非班注射液进行救治。两组患者均于术后统一对症护理。治疗结束后对两组患者的临床治疗效果、术后并发症发生率、血清C反应蛋白(CRP)、血清肌酸激酶同工酶(CK-MB)、肌钙蛋白T(cTnT)水平进行对比。结果: 治疗组11.11%的并发症总发生率低于对照组的33.33%,差异具有统计学意义(P<0.05);与治疗前相比,患者血清CRP、BNP、CK-MB、cTnT水平降低,差异具有统计学意义(P<0.05),治疗组患者血清CRP、BNP、CK-MB、cTnT水平低于对照组(P<0.05)。结论: 盐酸替罗非班注射液的应用能有效提高急性心肌梗死冠脉多支病变患者经皮冠状动脉介入术的手术效果,减轻患者疼痛、降低术后并发症发生率,对患者并发症的控制有积极作用,推测其机制与血清CRP、BNP、CK-MB、cTnT水平的降低有关。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	杨金勇

关键词 ：急性心肌梗死, 冠脉多支病变, 冠状动脉介入术, 盐酸替罗非班

Abstract：Objective: To investigate the efficacy and safety of tirofiban in patients with acute myocardial infarction after percutaneous coronary intervention. Methods: 126 cases of acute myocardial infarction patients with multivessel coronary artery disease from emergency treatment in our hospital were selected, simple randomization, randomly divided into the control group and the experiment with 63 cases in each group according to the random number table method. Patients in the control group were treated with percutaneous coronary intervention; The treatment group was treated with Tirofiban Hydrochloride Injection on the basis of the control group.Two groups of patients in the postoperative unified symptomatic care.After treatment, the clinical therapeutic effect, postoperative complications, serum C reactive protein (CRP), serum creatine kinase isoenzyme (CK-MB), cardiac troponin T (cTnT) levels were compared between the two groups. Results: Data show that the total incidence rate of complications of the treatment group 11.11% was significantly lower than the control group 33.33% (P < 0.05); compared with before treatment, serum CRP, BNP, CK-MB and cTnT levels in patients decreased (P < 0.05), the serum CRP, BNP, CK-MB, cTnT levels were lower in experiment group than the control group (P < 0.05). Conclusion: The application of Tirofiban Hydrochloride Injection can effectively improve the operation effect of percutaneous coronary intervention in acute myocardial infarction patients with multivessel coronary artery disease, reduce the pain of patients, reduce the incidence of postoperative complications, control of complications have a positive effect on reducing the machine, and serum CRP, BNP, CK-MB and cTnT levels.

Key words： Acute myocardial infarction Coronary multivessel disease Coronary intervention tirofiban

引用本文:

杨金勇. 盐酸替罗非班对急性心肌梗死冠脉多支病变经皮冠状动脉介入术后疗效及安全性研究[J]. 河北医学, 2017, 23(10): 1674-1677.
YANG Jinyong. Study on the Efficacy and Safety of Tirofiban in Patients with Acute Myocardial| Infarction after Percutaneous Coronary Intervention. 河北医学, 2017, 23(10): 1674-1677.

链接本文:

http://www.hbyxzzs.cn/CN/10.3969/j.issn.1006-6233.2017.10.026 或 http://www.hbyxzzs.cn/CN/Y2017/V23/I10/1674

[1]高润霖.急性心肌梗死诊断和治疗指南[J].中华心血管病杂志,2001,16(6):407~422.
[2] 杨艳敏,朱俊,谭慧琼,等.中国ST段抬高的急性心肌梗死临床特征及治疗现状[J].中华医学杂志,2005,85(31):2176~2182.
[3] 高润霖.从急性心肌梗死治疗指南看再灌注治疗策略的选择[J].中华心血管病杂志,2005,33(11):1061~1064.
[4] 黄从刚,李睿,左慧萍,等.急性心肌梗死危险因素和促发因素的青年人与中老年人暴露率比较[J].中华流行病学杂志,2007,28(3):282~285.
[5] 顾永群.影响急性心肌梗死患者近期预后的因素分析[J].中国基层医药,2009,16(9):1637~1638.
[6] 刘君,傅向华,马宁,等.急性心肌梗死经皮冠状动脉介入治疗后心肌灌注分级无再流现象对心室功能和收缩同步性的影响[J].中华心血管病杂志,2004,32(10):874~878.
[7] 陈韵岱,王长华.急性心肌梗死经皮冠状动脉介入治疗术后无复流的防治进展[J].中国循环杂志,2010,25(3):165~166.
[8] 田立群,巴英巴特,郑琼莉,等.替罗非班在急性心肌梗死经皮冠状动脉介入治疗中的应用[J].实用医学杂志,2008,24(3):442~444.
[9] 洪衡,王明生,王河,等.不同类型急性心肌梗死冠状动脉病变特点的观察[J].中国循环杂志,2007,22(3):187~190.
[10] 孙旻.中青年与老年人急性心肌梗死临床特点及冠状动脉病变比较[J].中国基层医药,2011,18(24):3367~3368.
[11] 高润霖,刘冰.经皮冠状动脉介入治疗指南[J].中华心血管病杂志,2002,37(12):707~718.
[12] 张红雨,王佩显,曹艳君,等.冠状动脉内注射替罗非班对急性心肌梗死患者介入治疗中无复流现象的疗效分析[J].第三军医大学学报,2010,27(20):25~29.
[13] 杨柳,韩英,张颖,等.替罗非班在冠状动脉介入手术治疗急性心肌梗死中的疗效及预后的影响[J].中国基层医药,2012,19(15):2337~2338.
[14] 王顺强.急性心肌梗死患者血清利钠肽水平与心肌梗死面积及预后的关系[J].中国基层医药,2013,20(10):1477~1478.
[15] 冯程娟,欧阳玲,杨松娣.联合检测hs-CRP、cTnI、Myo及CK-MB在急性心肌梗死诊断中的临床应用价值[J].中国现代医学杂志,2010,20(12):1881~1884.